Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Sartorius Stedim Biotech (GB:0RG8)
LSE:0RG8
RESEARCH TOOLSreports
Holding GB:0RG8?
Track your performance easily
See the Price Targets and Ratings of:
0RG8 Analyst Ratings
Moderate Buy
3 Buy
3 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
0RG8 Stock 12 Month Forecast
Average Price Target
€216.33
▲(30.19% Upside)
| Highest Price Target€270.00 | Average Price Target€216.33 | Lowest Price Target€155.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Jefferies
Reiterated
10/28/24
Goldman Sachs
Reiterated
10/17/24
Kepler Capital
Reiterated
10/17/24
RBC Capital
Reiterated
10/17/24
Barclays
Reiterated
09/13/24
J.P. Morgan
€275→€240
Buy
44.43%
Upside
Reiterated
07/29/24
Sartorius Stedim Biotech (DIM:FP) (SDMHF) PT Lowered to EUR240 at JPMorganJPMorgan analyst Richard Vosser lowered the price target on Sartorius Stedim Biotech (DIM:FP) (OTC: SDMHF) to EUR240.00 (from EUR275.00) while maintaining a Overweight rating.
Bernstein
€134
Sell
-19.36%
Downside
Downgraded
07/29/24
Sartorius Stedim Biotech (0RG8) was downgraded to a Sell Rating at Bernstein
Berenberg Bank
€182
Buy
9.53%
Upside
Reiterated
07/24/24
Berenberg Bank Sticks to Its Buy Rating for Sartorius Stedim Biotech (0RG8)
HSBC
€390→€360
Buy
116.65%
Upside
Reiterated
04/19/24
Sartorius Stedim Biotech (DIM:FP) (SDMHF) PT Lowered to EUR360 at HSBCHSBC analyst Sezgi Oezener lowered the price target on Sartorius Stedim Biotech (DIM:FP) (OTC: SDMHF) to EUR360.00 (from EUR390.00) while maintaining a Buy rating.
Best Analysts Covering Sartorius Stedim Biotech
Which Analyst Should I Follow If I Want to Buy GB:0RG8 and Sell After:
1 Month
xxx
Success Rate
9/14 ratings generated profit
Average Return
+5.76%
reiterated a xxx
rating 4 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 64.29% of your transactions generating a profit, with an average return of +5.76% per trade.
3 Months
xxx
Success Rate
8/14 ratings generated profit
Average Return
+2.29%
reiterated a xxx
rating 4 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 57.14% of your transactions generating a profit, with an average return of +2.29% per trade.
1 Year
Success Rate
3/6 ratings generated profit
Average Return
-9.55%
downgraded a sell rating 4 months ago
Copying Delphine Le Louet's trades and holding each position for 1 Year would result in 50.00% of your transactions generating a profit, with an average return of -9.55% per trade.
2 Years
xxx
Success Rate
3/6 ratings generated profit
Average Return
-19.52%
downgraded a xxx
rating 4 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 50.00% of your transactions generating a profit, with an average return of -19.52% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
0RG8 Analyst Recommendation Trends
Rating
Jun 24
Jul 24
Aug 24
Sep 24
Oct 24
Strong Buy
3
2
1
2
1
Buy
5
4
3
3
6
Hold
5
4
3
4
5
Sell
0
1
1
1
0
Strong Sell
0
0
0
0
0
total
13
11
8
10
12
Each month's total comprises the sum of three months' worth of ratings.
0RG8 Financial Forecast
0RG8 Stock Forecast FAQ
What is GB:0RG8’s average 12-month price target, according to analysts?
Based on analyst ratings, Sartorius Stedim Biotech’s 12-month average price target is €216.33.
What is GB:0RG8’s upside potential, based on the analysts’ average price target?
Sartorius Stedim Biotech has 30.19% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Sartorius Stedim Biotech a Buy, Sell or Hold?
Sartorius Stedim Biotech has a consensus rating of Moderate Buy, which is based on 3 buy ratings, 3 hold ratings and 0 sell ratings.
What is Sartorius Stedim Biotech’s share price target?
The average share price target for Sartorius Stedim Biotech is €216.33. This is based on 6 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is €270.00 ,and the lowest forecast is €155.00. The average share price target represents 30.19% Increase from the current price of €166.17.
The highest analyst share price target is €270.00 ,and the lowest forecast is €155.00. The average share price target represents 30.19% Increase from the current price of €166.17.
What do analysts say about Sartorius Stedim Biotech?
Sartorius Stedim Biotech’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 6 Wall Streets Analysts.
How can I buy shares of Sartorius Stedim Biotech?
To buy shares of GB:0RG8, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.